Fusion Family Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-212
Closed -$13K 187
2018
Q4
$13K Buy
212
+1
+0.5% +$70 ﹤0.01% 172
2018
Q3
$16K Buy
211
+3
+1% +$227 ﹤0.01% 178
2018
Q2
$15K Buy
208
+1
+0.5% +$71 ﹤0.01% 198
2018
Q1
$16K Buy
207
+2
+1% +$159 0.01% 181
2017
Q4
$15K Buy
+205
New +$15.6K ﹤0.01% 196
2017
Q3
Sell
-203
Closed -$14K 257
2017
Q2
$14K Buy
203
+1
+0.5% +$67 ﹤0.01% 188
2017
Q1
$14K Buy
+202
New +$14.2K 0.01% 187

Other funds holding GILD

Fusion Family Wealth's GILD Position: Q1 2019 in Review

Fusion Family Wealth sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 212 shares — an estimated $13K sold.

Fusion Family Wealth first reported a position in GILD in Q1 2017 and held it in 7 quarters. The position peaked at $16K in Q3 2018. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Fusion Family Wealth reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Fusion Family Wealth sold 212 Gilead Sciences shares in Q1 2019, an estimated $13K.
  • Fusion Family Wealth first reported a position in Gilead Sciences in Q1 2017 and held it in 7 quarters.
  • Fusion Family Wealth's Gilead Sciences position peaked at $16K in Q3 2018.
  • 1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Fusion Family Wealth's 13F filing for Q1 2019, filed 10 May 2019.